Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status

Clinical Cancer Research

Volumn 4, Issue 6, 1998, Pages 1573-1579

  Milas, Mira ^a   Yu, Dihua ^a   Sun, Dantong ^a   Pollock, Raphael E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SARCOMA CELL; TELOMERE; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL LINE; CONNECTIVE TISSUE; CONNECTIVE TISSUE CELLS; FIBROBLASTS; GENES, P53; HUMANS; LEIOMYOSARCOMA; LIVER; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SKELETAL; ORGAN SPECIFICITY; POINT MUTATION; RNA, MESSENGER; SARCOMA; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 0031750047     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Greider, C. W., and Blackburn, E. H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell, 57: 887-898, 1987.
2. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-29, 1989.
3. Watson, J. D. Origin of concatameric DNA. Nat. New Biol., 239: 197-201, 1972.
4. Muller, H. J. The remaking of chromosomes: the collecting net. Woods Hole, 13: 181-198, 1938.
5. McClintock, B. The stability of broken ends of chromosomes in Zea mays. Genetics, 41: 234-282, 1941.
6. Healy, K. C. Telomere dynamics and telomerase activation in tumor progression: prospects for prognosis and therapy. Oncol. Res., 7: 121-130, 1995.
7. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. Specific association of human telomerase activity with immortal cells and cancer. Science (Washington DC), 266: 2011-2015, 1994.
8. Rhyu, M. S. Telomeres, telomerase, and immortality. J. Natl. Cancer Inst., 87: 884-894, 1995.
9. Greider, C. W., and Blackburn, E. H. Telomeres, telomerase and cancer. Sci. Am., 274: 92-97, 1996.
10. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
11. Morin, G. B. Is telomerase a universal cancer target? J. Natl. Cancer Inst., 87: 859-860, 1995.
12. Wynford-Thomas, D., Bond, J. A., Wyllie, F. S., and Jones, C. J. Does telomere shortening drive selection for p53 mutation in human cancer? Mol. Carcinog., 12: 119-123, 1995.
13. Landberg, G., Nielsen, N. H., Nilsson, P., Emdin, S. O., Cajander, J., and Roos, G. Telomerase activity is associated with cell cycle deregulation in human breast cancer. Cancer Res., 57: 549-554, 1997.
14. ink4 and telomerase in immortalisation of human cells. Oncogene, 11: 971-976, 1995.
15. Wright, W. E., and Shay, J. W. The two-stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol., 27: 383-389, 1992.
16. DiPaolo, J. A. Relative difficulties in transforming human and animal cells in vitro. J. Natl. Cancer Inst., 70: 3-8, 1983.
17. Shay, J. W., Pereira-Smith, O. M., and Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res., 196: 33-39, 1991.
18. ink4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol. Cell. Biol., 75: 4745-4753, 1995.
19. Stratton, M. R., Moss, S., Warren, W., Patterson, H., Clark, J., Fisher, C., Fletcher, C. D. M., Ball, A., Thomas, M., Gusterson, B. A., and Cooper, C. S. Mutation of the p53 gene in human soft tissue sarcomas: association with abnormalities of the RB1 gene. Oncogene, 5: 1297-1301, 1990.
20. Pollock, R. E., Lang, A., Luo, J., El-Naggar, A. K., and Yu, D. Soft tissue sarcoma metastasis from clonal expansion of p53 mutated tumor cells. Oncogene, 12: 2035-2039, 1996.
21. Hu, M., Pollock, R. E., Nakamura, T., and Nicholson, G. L. Human peritumoral and lung fibroblasts produce paracrine motility factors for recently established human sarcoma cell strains. Int. J. Cancer, 62: 585-592, 1995.
22. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell, 90: 785-795, 1997.
23. Zhu, X., Kumar, R., Mandal, M., Sharma, N., Sharma, H. W., Dhingra, U., Sokoloski, J. A., Hsiao, R., and Narayanan, R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc. Natl. Acad. Sci. USA, 93: 6091-6095, 1996.
24. Tsukada, T., Tomooka, Y., Takai, S., Ueda, Y., Nishikawa, S., Yagi, T., Tokunaga, T., Takeda, N., Suda, Y., Abe, S., Matsuo, I., Ikawa, Y., and Aizawa, S. Enhanced proliferative potential in culture cells from p53-deficient mice. Oncogene, 8: 3313-3322, 1993.
25. Harvey, M., Sands, A. T., Weiss, R. S., Hegi, M. E., Wiseman, R. W., Pantazis, P., Giovanella, B. C., Tainsky, M. A., Bradley, A., and Donehower, L. A. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene, 8: 2457-2467, 1993.
26. Parfett, C. L. J., and Denhardt, D. T. Changes in gene expression during senescence/immortalization of mouse embryo fibroblasts. In: E. Wang and H. R. Warner (eds.), Growth Control during Cell Aging, pp. 31-40. Boca Raton, FL: CRC Press, 1989.
27. Chadeneau, C., Siegel, P., Harley, C. B., Muller, W. J., and Bacchetti, S. Telomerase activity in normal and malignant murine tissues. Oncogene, 11: 893-898, 1995.
28. Prowse, K. R., and Greider, C. W. Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA, 92: 4818-4822, 1995.
29. Wright, W. E., Shay, J. W., and Piatyszek, M. A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity, and sensitivity. Nucleic Acids Res., 23: 3794-3795, 1995.
30. INK4a. Cell, 88: 593-602, 1997.
31. Gollahon, L. S., and Shay, J. W. Immortalization of human mammary epithelial cells transfected with mutant p53 (273 his). Oncogene, 12: 715-725, 1996.
32. Pandita, T. K., Hall, E. J., Hei, T. K., Piatyszek, M. A., Wright, W. E., Piao, C. Q., Pandita, R. K., Willey, J. C., Geard, C. R., Kastan, M. B., and Shay, J. W. Chromosome end-to-end associations and telomerase activity during cancer progression in human cells after treatment with α-particles simulating radon progeny. Oncogene, 13: 1423-1430, 1996.
33. Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E., and de Lange, T. Telomerase activation in mouse mammary tumors: lack of detectable telomere shortening and evidence for regulation of telomerase RNA with cell proliferation. Mol. Cell. Biol., 16: 3765-3772, 1996.
34. Roos, G., Landberg, G., Nielsen, N. H., Nilsson, P., and Emdin, S. O. Telomerase activity and cell cycle deregulation in human breast cancer. Proc. Am. Assoc. Cancer Res., 38: 503, 1997.
35. Wu, X., Li, H., Kemp, B., Gu, J., Honn, S., Izzo, J., and Spitz, M. R. Correlations between telomerase activity and p53 and cyclin D1 expression in non-small cell lung cancer. Proc. Am. Assoc. Cancer Res., 38: 168, 1997.
36. Xu, H. J., Zhou, Y., Ji, W., Perng, G. S., Kruzelock, R., Kong, C. T., Bast, R. C., Mills, G. B., Li, J., and Hu, S. X. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene, 15: 2589-2596, 1997.
37. Klingelhutz, A. J., Foster, S. A., and McDougall, J. K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature (Lond.), 380: 79-82, 1996.
38. Lundblad V., and Wright, W. E. Telomeres and telomerase: a simple picture becomes complex. Cell, 87: 369-375, 1996.
39. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. Telomerase catalytic subunit homologs from fission yeast and human. Science (Washington DC), 277: 955-959, 1997.